Validating cancer drug targets

被引：107

作者：

Benson, John D. ^{[1
]}

Chen, Ying-Nan P. ^{[1
]}

Cornell-Kennon, Susan A. ^{[1
]}

Dorsch, Marion ^{[1
]}

Kim, Sunkyu ^{[1
]}

Leszczyniecka, Magdalena ^{[1
]}

Sellers, William R. ^{[1
]}

Lengauer, Christoph ^{[1
]}

机构：

[1] Novartis Inst Biomed Res, Cambridge, MA 02139 USA

来源：

NATURE | 2006年 / 441卷 / 7092期

关键词：

D O I：

10.1038/nature04873

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

A cancer drug target is only truly validated by demonstrating that a given therapeutic agent is clinically effective and acts through the target against which it was designed. Nevertheless, it is desirable to declare an early-stage drug target as 'validated' before investing in a full-scale drug discovery programme dedicated to it. Although the outcome of validation studies can guide cancer research programmes, strictly defined universal validation criteria have not been established.

引用

页码：451 / 456

页数：6

共 50 条

[21] PDGF receptors as cancer drug targets
Östman, A
ANNALS OF ONCOLOGY, 2006, 17 : 26 - 26
[22] Transcription factors as drug targets in cancer
Hurst, HC
EUROPEAN JOURNAL OF CANCER, 1996, 32A (11) : 1857 - 1863
[23] Emerging targets in cancer drug resistance
Kumar, Shashank
Kushwaha, Prem Prakash
Gupta, Sanjay
CANCER DRUG RESISTANCE, 2019, 2 (02) : 161 - 177
[24] Homing in on new cancer drug targets?
Senior, Kathryn
LANCET ONCOLOGY, 2013, 14 (02): : E49 - E49
[25] PDGF receptors as cancer drug targets
Ostman, A
Pietras, K
Hägerstrand, D
Furuhashi, M
Abe, M
Robinson, S
Wu, Y
Hicklin, DJ
Baranowska-Kortylewicz, J
Nister, M
Heldin, CH
Rubin, K
ANNALS OF ONCOLOGY, 2005, 16 : 21 - 21
[26] Platelets and cancer: pathology and drug targets
Suzuki-Inoue, Katsue
PLATELETS, 2018, 29 (08) : 771 - 772
[27] Protein kinases as drug targets in cancer
Arslan, Mehmet Alper
Kutuk, Ozgur
Basaga, Huveyda
CURRENT CANCER DRUG TARGETS, 2006, 6 (07) : 623 - 634
[28] Epigenetic Targets and Cancer Drug Discovery
Woster, Patrick M.
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 45, 2010, 45 : 245 - 260
[29] PDGF receptors as cancer drug targets
Pietras, K
Sjöblom, T
Rubin, K
Heldin, CH
Östman, A
CANCER CELL, 2003, 3 (05) : 439 - 443
[30] INGs are potential drug targets for cancer
Runyun Zhang
Jianhua Jin
Juanjuan Shi
Yongzhong Hou
Journal of Cancer Research and Clinical Oncology, 2017, 143 : 189 - 197

← 1 2 3 4 5 →